Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Cipla Ltd

Cipla Ltd share price and stock overview

Cipla Ltd (NSE: CIPLA, BSE: 500087) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE059A01026 and a face value of Rs 2. As of 29 September 2026, it trades at Rs (1,386.80) with a market capitalisation of Rs 112205.15 crore. Figures are live and subject to change.

Cipla Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln
NSE BSE
1,386.80 3.10 (0.22%) upARrowC
As on: 29-Sep-2026 , 02:35 PM
Market Cap(₹Cr) 112205.15
Book Value(₹Cr) 423.34903
BSE Code : 500087 NSE Symbol : CIPLA EPS(TTM) : 40.59 ISIN Demat : INE059A01026 P/E(TTM) : 34.22 Face Value(₹) : 2 Div & Yield % : 0.94

Today Market

Stock Performance

Today Market

Today's High

72,684.90

Todday's Low

72,064.00

Open at

72,633.68

Previous Close

72,771.72

Volumes

0.00

Avg Price

-345.70

Historical Performance

News

28 Sep 26
Cipla Ltd. to review financial results at a board meeting on October 27, 2026
Cipla Ltd. will hold a board meeting on Tuesday, October 27, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, the company said in a filing.
24 Sep 26
Cipla Ltd.’s committee approved equity share allotments under employee stock schemes
Cipla Ltd. announced that its Operations and Administrative Committee has allotted 12,168 fully paid-up equity shares of INR 2 each under the Employee Stock Option Scheme 2013 -A and the Cipla Employee Stock Appreciation Rights Scheme 2021, increasing the company’s issued, subscribed and paid-up share capital to INR 1,61,57,41,230 comprising of 80,78,70,615 equity shares.
22 Sep 26
Venkata Sai Mungara to lead Cipla USA's manufacturing and supply chain operations
Cipla Ltd. announced that Venkata Sai Mungara, currently Global Head Supply Chain, will transition to the role of Chief of Manufacturing and Supply Chain Operations of Cipla USA Inc.
27 Aug 26
Cipla’s Aspergen joint venture acquires 100% stake in Aspergen Inc., USA
Cipla Ltd. announced that Aspergen Limited, a 60:40 joint venture with Kemwell Biopharma Private Limited, has acquired 100% stake in Aspergen Inc.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
28-09-26 1399.70 1405.00 1380.50 1383.70 711020 26653 987209924.80 22780.25
25-09-26 1402.90 1421.00 1388.40 1399.70 1166527 35556 1637231280.40 23140.50
24-09-26 1375.00 1419.00 1364.60 1399.00 1580784 52856 2210580630.80 23063.10
23-09-26 1382.40 1387.00 1371.80 1383.00 651221 22885 897020664.80 23446.80
22-09-26 1386.30 1388.70 1364.50 1384.10 767139 36733 1051822122.20 23329.00
21-09-26 1383.20 1405.20 1378.30 1386.10 895131 31866 1245648848.80 23414.30
18-09-26 1371.70 1394.50 1371.70 1394.50 1386584 31702 1920252386.40 23346.40
17-09-26 1362.50 1385.00 1351.60 1376.30 730653 25890 1003182854.50 23270.60
16-09-26 1351.00 1363.70 1344.30 1358.00 911572 46589 1236664102.50 23217.60
15-09-26 1355.00 1362.70 1347.70 1351.00 1225305 77711 1660047265.70 23118.60
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

112205.15

PE Ratio

34.22

PB Ratio

3.28

Dividend Yield

0.94

ROE

10.60

ROCE

13.88

Book Value (₹)

423.34903

Face Value (₹)

2

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 161460683 19.99 161460683 2
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 161460683 19.99 161460683 2
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 73826320 9.14 73826320 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 73826320 9.14 73826320 2
Total ShareHolding for Promoter & Group 235287003 29.13 235287003 4
plus   Publice Share Holding
plus  Institution
Government(Central / State) 37588 0.00 37588 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 827090 0.10 824865 12
Foreign Bank 21367 0.00 21367 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 162740630 20.15 162740630 790
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 94728380 11.73 94728380 31
Mutual Funds / UTI 165596877 20.50 165596877 46
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 17787702 2.20 17787702 36
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 441739634 54.68 441737409 919
plus  Non Institution
Bodies Corporate 3716967 0.46 3712367 1586
Clearing Members 86504 0.01 86504 7
Directors & their Relatives 6918 0.00 6918 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 9426519 1.17 7979019 15952
Foreign Non Institution Other 375 0.00 375 1
Hindu Undivided Families 1368320 0.17 1368320 4986
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 55445819 6.86 54453944 131
Individuals holding nominal share capital up to Rs. 1 lakh 55193787 6.83 54440530 555059
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 633154 0.08 633154 29
Others 2513551 0.31 2513551 3
Sub Total 128391914 15.89 125194682 577755
Total Public Shareholding 570131548 70.57 566932091 578674
Total of Promoter & Public ShareHolding 805418551 99.70 802219094 578678
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 2426765 0.30 2426765 1
Total Shares held by Custodians and against which Depository Receipts have been issued 2426765 0.30 2426765 1
Grand Total 807845316 100.00 804645859 578679

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales28,162.5927,547.6225,774.0922,753.1221,763.34
OPM (%)19.5324.7622.8818.5516.89
OP5,499.546,820.815,896.724,220.773,675.39
Other Income882.01861.87746.57475.45280.91
PBIDT6,489.007,989.776,842.805,320.004,651.57
INTEREST54.3962.0189.88109.54106.35
PBDT6,434.617,927.766,752.925,210.464,545.22
PBT4,947.726,820.815,507.083,855.933,311.15
EO-275.910.00-194.82-182.42-182.12
PBT after EO5,223.636,820.815,701.904,038.353,493.27
TAXES1,353.841,529.761,546.591,202.86933.80
PAT3,879.235,272.524,121.552,801.912,516.75
EPS48.0065.2451.0134.6931.17
Raw Material20.7419.6420.2524.2625.42
Power and Fuel1.481.441.421.551.52
Employee Cost19.0517.5416.7216.8316.22
Other Manufacturing Expenses2.602.422.492.542.76
Selling and Administration Expenses15.3814.5314.8615.4014.44
Miscellaneous Expenses3.422.693.142.562.41
Revenue (Growth %) 2.236.8813.284.5513.59
PBIDT (Growth %)-18.7816.7628.6214.372.95
PAT (Growth %) -26.4327.9347.1011.334.65
PBIDT (Margin %)23.0429.0026.5523.3821.37
PAT (Margin %) 13.7719.1415.9912.3111.56

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 161.56161.52161.47161.43161.36161.29
Reserves Total 34039.5531937.7227812.4524476.6622352.1919766.27
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds34201.1132099.2427973.9224638.0922513.5519927.56
Secured Loans 0.000.000.000.000.000.00
Unsecured Loans 124.97117.3845.5550.0923.4552.12
Total Debt124.97117.3845.5550.0923.4552.12
Other Liabilities341.32196.88154.87186.98181.38209.87
Total Liabilities34667.4032413.5028174.3424875.1622718.3820189.55
APPLICATION OF FUNDS :
Gross Block 10499.728670.098045.967766.427388.297065.54
Less : Accumulated Depreciation 5305.914792.464327.333957.423478.372999.09
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 5193.813877.633718.633809.003909.924066.45
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress977.59638.40670.27504.25267.68355.11
Producing Properties0.000.000.000.000.000.00
Investments 17616.3317350.9913793.7611909.3510973.689725.83
Current Assets, Loans & Advances
Inventories 4353.713607.123254.283277.363485.813085.81
Sundry Debtors 3396.743859.992681.752888.492794.483035.37
Cash and Bank Balance518.60278.45333.20966.461428.03874.80
Loans and Advances 2874.533774.354205.023467.381587.921191.36
Total Current Assets11143.5811519.9110474.2510599.699296.248187.34
Less : Current Liabilities and Provisions
Current Liabilities 2893.462319.362091.722038.442020.032044.15
Provisions 932.23832.86754.53646.74631.39625.13
Total Current Liabilities & Provisions3825.693152.222846.252685.182651.422669.28
Net Current Assets7317.898367.697628.007914.516644.825518.06
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets339.49249.02211.07249.95234.440.00
Deferred Tax Liability289.26229.14243.71286.08313.69104.91
Net Deferred Tax50.2319.88-32.64-36.13-79.25-104.91
Other Assets3511.552158.912396.32774.181001.53629.01
Total Assets34667.4032413.5028174.3424875.1622718.3820189.55
Contingent Liabilities986.05936.62674.73552.80619.711700.79

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities -426.72-424.77-708.83-1,073.93-1,321.90
Investing Activities -2,464.14-2,758.09-2,882.90-2,308.84-1,343.73
Net Cash Flow -117.43-147.81135.04-81.78166.06
Operating Activities 2,773.433,035.053,726.773,300.992,831.69

Peers

Balance Sheet Financial Ratios Profit & Loss
Aarti Pharmalabs...

960.90

(+5.13%)
Accent Microcell...

673.15

(-0.55%)
Accretion Pharma...

210.95

(+4.30%)
Achyut Healthcar...

Advanced Enzyme ...

283.10

(-0.02%)
Akums Drugs & Ph...

824.20

(+3.03%)
Albert David Ltd

888.75

(+4.94%)
Alembic Pharmace...

859.25

(+0.57%)

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
YKH
Y K Hamied
Chairman & Non Executive Dir.
Executive
PRR
P R Ramesh
Vice Chairman / Independent Non Executive Director
Executive
Independent Directors
KH
Kamil Hamied
Non-Exec & Non-Independent Dir
Ind.
AJJ
Abhijit J. Joshi
Non-Exec & Non-Independent Dir
Ind.
AZ
Adil Zainulbhai
Non-Exec & Non-Independent Dir
Ind.
DBB
Dr Balram Bhargava
Independent Non Exe. Director
Ind.
MPV
Mandar Purushottam Vaidya
Independent Non Exe. Director
Ind.
MH
MAYA HARI
Independent Non Exe. Director
Ind.
SNP
SHARMILA NITIN PARANJPE
Independent Non Exe. Director
Ind.
Other Officials
AG
Achin Gupta
MD / Global CEO / Global COO
Board
RC
Rajendra Chopra
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Cipla Ltd? −

Cipla Ltd trades on NSE under CIPLA and on BSE under code 500087. The ISIN is INE059A01026 and the face value is Rs 2.

What is the share price of Cipla Ltd today? +

As of 29 September 2026, Cipla Ltd trades at Rs 1,386.80, a change of 3.10 (0.22%) on the day. Prices are live and subject to change.

What is the market capitalisation of Cipla Ltd? +

As of 29 September 2026, Cipla Ltd has a market cap of about Rs 112205.15 crore. This figure is live and moves with the share price.

Is Cipla Ltd profitable? +

In March 2026, Cipla Ltd reported a profit after tax of Rs 3,879.23 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Cipla Ltd? +

: As of 29 September 2026, the PE (TTM) for Cipla Ltd is 34.22 and the price-to-book ratio is 3.28. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Cipla Ltd pay a dividend? +

As of 29 September 2026, the dividend yield for Cipla Ltd is 0.94%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Cipla Ltd? +

As of the latest disclosed pattern, promoters hold 29.13% of Cipla Ltd. Public shareholding is 70.57%, including mutual funds at 20.50% and foreign institutional investors at 20.15%.

What were the latest annual financials of Cipla Ltd? +

In March 2026, Cipla Ltd reported net sales of Rs 28,162.59 crore, revenue growth of 2.23%, and earnings per share of Rs 48.00.